AU5350190A - Methods and compositions for the identification of patients sensitive to interferon alpha - Google Patents

Methods and compositions for the identification of patients sensitive to interferon alpha

Info

Publication number
AU5350190A
AU5350190A AU53501/90A AU5350190A AU5350190A AU 5350190 A AU5350190 A AU 5350190A AU 53501/90 A AU53501/90 A AU 53501/90A AU 5350190 A AU5350190 A AU 5350190A AU 5350190 A AU5350190 A AU 5350190A
Authority
AU
Australia
Prior art keywords
compositions
identification
methods
interferon alpha
patients sensitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53501/90A
Inventor
Albert B. Deisseroth
O. M. Zack Howard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU5350190A publication Critical patent/AU5350190A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU53501/90A 1989-05-19 1990-01-29 Methods and compositions for the identification of patients sensitive to interferon alpha Abandoned AU5350190A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35427289A 1989-05-19 1989-05-19
US354272 1989-05-19

Publications (1)

Publication Number Publication Date
AU5350190A true AU5350190A (en) 1990-12-18

Family

ID=23392567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53501/90A Abandoned AU5350190A (en) 1989-05-19 1990-01-29 Methods and compositions for the identification of patients sensitive to interferon alpha

Country Status (2)

Country Link
AU (1) AU5350190A (en)
WO (1) WO1990014593A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4021627B2 (en) * 2000-03-22 2007-12-12 株式会社東芝 Carrier for gene detection and its use to detect the effectiveness of interferon therapy
JP3983985B2 (en) * 2000-03-22 2007-09-26 株式会社東芝 Polymorphic gene of MxA protein and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745053A (en) * 1983-07-08 1988-05-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyojo Process for producing human interferon and method for assaying the interferon productivity of blood
FR2560212B1 (en) * 1984-02-24 1989-12-29 Unicet MONOCLONAL ANTIBODIES AGAINST INTERFERON A2 AND HYBRIDOMAS PRODUCING SUCH ANTIBODIES

Also Published As

Publication number Publication date
WO1990014593A1 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
AU3076189A (en) Novel compositions and methods of use thereof
AU4418789A (en) Synthesis of camptothecin and analogs thereof
AU7315587A (en) Sportman's article of equipment
NZ224903A (en) C-terminal alpha aminoboronic acid derivatives and pharmaceutical compositions
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
NZ220215A (en) Tetrahydronaphthalene derivatives and pharmaceutical compositions
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
HU896428D0 (en) Process for the preparation of imidazoles and pharmaceutical compositions thereof
AR243175A1 (en) Morphologically homogenous forms of famotidine and processes for their preparation
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
AU585662B2 (en) Settable compositions and methods of use thereof
AU4878390A (en) Transparent antiperspirant compositions and method of preparation
AU8015587A (en) 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
IL89534A0 (en) Preparation of 1-cyclopropyl-quinolone-carboxylic acids and derivatives thereof and certain novel n-cyclopropyl-anilines used therein
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
AU6774090A (en) Compositions of antiallergics and antihistamines and methods for their use
AU623165B2 (en) Method of inhibiting the spread of disease and infection in structures
AU6643690A (en) Polypeptide inhibitors of gamma interferon
PH27533A (en) Adenosine derivative pharmaceutical composition and method of use thereof
GB9022572D0 (en) Use of glycoprotein extracts of gram(-)bacteria for the manufacture of comestic or dermatological compositions and compositions containing them
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
AU5350190A (en) Methods and compositions for the identification of patients sensitive to interferon alpha
EP0323645A3 (en) Extract of chlorella and use thereof
NZ219748A (en) Indenopyrimidines and pharmaceutical compositions